Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial
M-SIMI
Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Unconditional Travel Subsidies on Measles Vaccination in Western Kenya: The Mobile and Scalable Innovations for Measles Immunization (M-SIMI) Trial
1 other identifier
interventional
537
0 countries
N/A
Brief Summary
The overall objective is to test the impact of short message service (SMS) reminders, with or without unconditionally provided mobile-money incentives, can improve measles vaccination coverage in rural western Kenyan infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2016
CompletedFirst Posted
Study publicly available on registry
September 19, 2016
CompletedStudy Start
First participant enrolled
December 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2017
CompletedMarch 1, 2018
February 1, 2018
4 months
September 8, 2016
February 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measles vaccination coverage
Proportion of children receiving measles vaccination by 10 months of age by study arm
10 months
Secondary Outcomes (4)
Time to measles vaccination (in days) using Kaplan-Meier Survival Analysis
12 months
Proportion of children who receive measles vaccination stratified by demographic variables
10 months
Measles vaccination coverage at 12 months
12 months
Vaccination coverage for second dose of measles vaccine at 24 months.
24 months
Study Arms (3)
Control
NO INTERVENTIONAll enrolled caregivers will receive a congratulatory text message at enrollment which indicates who is conducting the study and which also includes a general-health related saying, "The greatest wealth is health". No additional text messages or travel subsidies will be sent to caregivers randomized to the control arm.
SMS reminder
EXPERIMENTALAt enrollment, participants will be told to expect 2 SMS reminders for measles vaccine; first, at 3 days before and second, on the day before the scheduled measles vaccine at 9 months of age. At most, enrolled caregivers will receive three text messages (two for the measles vaccine and one for welcoming mother to the study). Text messages will be sent in English, Kiswahili or Dholuo language, according to the mother's preference. These reminders will have information about the child's scheduled immunization date.
SMS reminder + Unconditional Incentive
EXPERIMENTALParticipants will receive SMS reminders as described in the SMS reminder arm. Additionally, participants will be sent a 150 Kenyan Shillings (KES) incentive to the mobile phone number they provided at enrollment. The incentive will be delivered three days before the child turns nine months (i.e. sent on the same day as the first SMS reminder). Caregivers will receive the mobile-money incentive unconditionally. The intent of the incentive is to help offset the costs associated with transportation to the clinic. The transaction costs associated with mobile-money transactions will be borne by the study such that mothers will receive the full 150 KES.
Interventions
Caregivers will receive two text message reminders for their child's measles immunization scheduled for 9 months of age
A mobile-money incentive in the amount of 150 Kenyan Shillings will be transferred to the enrolled caregiver's mobile phone when the child reaches nine months of age
Eligibility Criteria
You may qualify if:
- Caregiver of infant aged 6-8 months at time of enrollment
- Self-reported resident of one of the study villages; where the definition of a resident is defined by caregiver
- Willing to sign informed consent for the study
You may not qualify if:
- Child of enrolled caregiver has already received one dose of measles vaccine, not including any supplemental measles vaccines
- Caregiver plans to move away in the next 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Bloomberg School of Public Healthlead
- Kenya Medical Research Institutecollaborator
- Bill and Melinda Gates Foundationcollaborator
Related Publications (3)
Kagucia EW, Ochieng B, Were J, Hayford K, Obor D, O'Brien KL, Gibson DG. Impact of mobile phone delivered reminders and unconditional incentives on measles-containing vaccine timeliness and coverage: a randomised controlled trial in western Kenya. BMJ Glob Health. 2021 Jan;6(1):e003357. doi: 10.1136/bmjgh-2020-003357.
PMID: 33509838DERIVEDPalmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
PMID: 32813276DERIVEDGibson DG, Kagucia EW, Were J, Obor D, Hayford K, Ochieng B. Text Message Reminders and Unconditional Monetary Incentives to Improve Measles Vaccination in Western Kenya: Study Protocol for the Mobile and Scalable Innovations for Measles Immunization Randomized Controlled Trial. JMIR Res Protoc. 2019 Jul 9;8(7):e13221. doi: 10.2196/13221.
PMID: 31290405DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Scientist
Study Record Dates
First Submitted
September 8, 2016
First Posted
September 19, 2016
Study Start
December 6, 2016
Primary Completion
April 4, 2017
Study Completion
April 4, 2017
Last Updated
March 1, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share